Skip to main content
Inify Laboratories AB logo

Inify Laboratories AB — Investor Relations & Filings

Ticker · INIFY ISIN · SE0017486103 LEI · 549300306YYJ3BX3VB98 ST Human health and social work activities
Open in API
Filings indexed 341 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country SE Sweden
Listing ST INIFY

About Inify Laboratories AB

https://www.inify.com/

Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. The company utilizes a fully digital, standardized, and AI-supported workflow for histopathology analysis. This integrated service model is designed to optimize the entire diagnostic process, from sample receipt to final report, ensuring high quality and significantly reduced turnaround times for clinical partners. Initially focused on prostate cancer, the company has expanded its diagnostic capabilities to include other areas such as gastroenterology. By streamlining the clinical pathway, Inify Laboratories enables healthcare providers to receive faster results, which facilitates earlier patient follow-up and treatment planning.

Recent filings

Filing Released Lang Actions
Inify Laboratories announces CQC registration and full operational launch of its state-of-the-art UK histopathology laboratory - Attachment: Inify_Laboratories_CQC_registration.pdf
Regulatory Filings Classification · 30% confidence The document is a corporate press release announcing the Care Quality Commission (CQC) registration and operational launch of a UK histopathology laboratory. It does not contain financial results, governance changes, regulatory filings, or other specialized content. It is not reporting on voting, shares, dividends, or transactions, nor is it an investor presentation or annual/interim report. Therefore, it does not fit any specific category and defaults to the general regulatory/press announcement category.
2026-05-27 English
Inify Laboratories announces CQC registration and full operational launch of its state-of-the-art UK histopathology laboratory
Regulatory Filings Classification · 65% confidence The document is a public press release announcing the company’s successful registration with the Care Quality Commission and the full operational launch of its new UK laboratory. It does not contain financial statements, management or board changes, M&A details, share issues, or quarterly results. It is a general regulatory/operational announcement rather than a formal financial report or shareholder document. Thus it falls under the generic Regulatory Filings category (RNS).
2026-05-27 English
Inify Laboratories AB (publ) - Bulletin from the Annual General Meeting 2026 - Attachment: Inify_Laboratories_Bulletin_from_Annual_General_Meeting_2026.pdf
AGM Information Classification · 91% confidence The document is titled “Bulletin from the Annual General Meeting 2026” and provides a summary of the resolutions adopted at the AGM (adoption of accounts, disposition of financial results, discharge from liability, remuneration, board elections, etc.). It is a post‐meeting summary of AGM resolutions rather than the full annual report or an earnings release. It is not announcing publication of a report nor detailing vote counts, so it best fits the AGM Information category.
2026-05-21 English
Inify Laboratories AB (publ) - Kommuniké från årsstämma 2026 - Attachment: Inify_Laboratories_AB_Kommunike_fran_bolagsstamma_2026_05_20.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 10% confidence The document is a post-annual general meeting communique summarizing the resolutions passed at the 2026 AGM, including approval of financial statements, discharge of directors, remuneration decisions, and board re-elections. This is an official declaration of voting results from a shareholder meeting, matching the Declaration of Voting Results & Voting Rights Announcements category.
2026-05-21 Swedish
Inify Laboratories AB (publ) - Bulletin from the Annual General Meeting 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is titled “Bulletin from the Annual General Meeting 2026” and summarises the AGM resolutions (adoption of accounts, discharge of liability, board elections, remuneration, auditor appointment, etc.). It reports on the outcome of shareholder votes at the AGM rather than providing full financial statements or presentations. This fits the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-21 English
Inify Laboratories AB (publ) - Kommuniké från årsstämma 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a post-AGM communiqué summarizing the resolutions and voting outcomes (approval of financials, discharge, remuneration, re-election of board members and auditor) from the Annual General Meeting. It is an official announcement of shareholder vote results at the AGM, matching the Declaration of Voting Results category.
2026-05-21 Swedish

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.